School of Science and Technology, Department of Chemistry and Forensics, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.
Bavarian Polymer Institute, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dr.-Mack-Straße, 77, 90762 Fürth, Germany.
J Colloid Interface Sci. 2023 Feb;631(Pt A):165-180. doi: 10.1016/j.jcis.2022.10.094. Epub 2022 Oct 22.
Silver nanoparticles (AgNPs) have found widespread commercial applications due to their unique physical and chemical properties. However, their relatively poor stability remains a main problem. An ideal way to improve the stability of AgNPs is not only to endow colloidal stability to individual nanoparticles but also to protect them from environmental factors that induce their agglomeration, like variation of ionic strength and pH, presence of macromolecules, etc. Mesoporous calcium carbonate vaterite crystals (CaCO vaterite) have recently attracted significant attention as inexpensive and biocompatible carriers for the encapsulation and controlled release of both drugs and nanoparticles. This work aimed to develop an approach to load AgNPs into CaCO vaterite without affecting their properties. We focused on improving the colloidal stability of AgNPs by using different capping agents, and understanding the mechanism behind AgNPs loading and release from CaCO crystals. Various methods were applied to study the AgNPs and CaCO crystals loaded with AgNPs (CaCO/AgNPs hybrids), such as scanning and transmission electron microscopy, X-ray diffraction, infrared and mass spectrometry. The results demonstrated that polyvinylpyrrolidone and positively charged diethylaminoethyl-dextran can effectively keep the colloidal stability of AgNPs during co-precipitation with CaCO crystals. CaCO/AgNPs hybrids composed of up to 4 % weight content of nanoparticles were produced, with the loading mechanism being well-described by the Langmuir adsorption model. In vitro release studies demonstrated a burst release of stable AgNPs at pH 5.0 and a sustained release at pH 7.5 and 9.0. The antibacterial studies showed that these hybrids are effective against Escherichia coli, methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa, three important bacteria responsible for nosocomial infections. The developed approach opens a new way to stabilise, protect, store and release AgNPs in a controlled manner for their use as antimicrobial agents.
由于具有独特的物理和化学性质,纳米银颗粒(AgNPs)已经得到了广泛的商业应用。然而,其相对较差的稳定性仍然是一个主要问题。改善 AgNPs 稳定性的理想方法不仅是赋予单个纳米颗粒胶体稳定性,还要保护它们免受环境因素的影响,如离子强度和 pH 值的变化、大分子的存在等,这些因素会诱导它们聚集。介孔碳酸钙球霰石晶体(CaCO 球霰石)作为廉价且生物相容的药物和纳米颗粒的封装和控制释放载体,最近引起了人们的极大关注。本工作旨在开发一种方法,将 AgNPs 负载到 CaCO 球霰石中,而不影响其性能。我们专注于使用不同的封端剂来提高 AgNPs 的胶体稳定性,并了解 AgNPs 从 CaCO 晶体中负载和释放的机制。采用多种方法研究负载有 AgNPs 的 AgNPs 和 CaCO 晶体(CaCO/AgNPs 杂化物),如扫描和透射电子显微镜、X 射线衍射、红外和质谱。结果表明,聚维酮和带正电荷的二乙氨基乙基葡聚糖可以在与 CaCO 晶体共沉淀时有效保持 AgNPs 的胶体稳定性。制备了高达 4%重量含量纳米颗粒的 CaCO/AgNPs 杂化物,负载机制可以很好地用 Langmuir 吸附模型来描述。体外释放研究表明,在 pH 值为 5.0 时,AgNPs 会发生快速释放,在 pH 值为 7.5 和 9.0 时会发生持续释放。抗菌研究表明,这些杂化物对引起医院感染的三种重要细菌,即大肠杆菌、耐甲氧西林金黄色葡萄球菌和铜绿假单胞菌,具有抗菌活性。所开发的方法为以控制方式稳定、保护、储存和释放 AgNPs 以将其用作抗菌剂开辟了新途径。